Treatment with granulocyte colony-stimulating factor decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus-infected persons

Journal of Infectious Diseases

Volumn 180, Issue 6, 1999, Pages 1819-1826

  Nielsen, Susanne D ^a   Clark, Dawn R ^c   Hutchings, Marianne ^b   Dam Larsen, Sanne ^a   Repping, Sjoerd ^c   Nielsen, Jens O ^a   Mathiesen, Lars ^a   Miedema, Frank ^c   Hansen, John Erik S ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b KAS Herlev ^*  (Denmark)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL COUNT; CELL FUNCTION; CELL MATURATION; CELL MOTILITY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE THERAPY; HELPER CELL; HEMATOPOIESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTOPOIESIS; MALE; PRIORITY JOURNAL; PROLYMPHOCYTE; THYMUS;

ANIMALS; ANTIGENS, CD34; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FILGRASTIM; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MICE; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0032710496     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315136     Document Type: Article

References (51)

1. - immunodeficient patients. Science 1995; 270:470-5.
2. 2. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048-57.
3. 3. Kohn DB, Weinberg KI, Nolta JA, et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1995; 1:1017-23.
4. 4. Woffendin C, Ranga U, Yang ZY, Xu L, Nabel GJ. Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc Natl Acad Sci USA 1996; 93:2889-94.
5. + hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture. J Virol 1996; 70:4352-60.
6. + cells from HIV-1 infected donors using retroviral vectors containing anti HIV-1 genes. Blood 1997; 89: 2259-67.
7. 7. Bonyhadi ML, Moss K, Voytovich A, et al. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J Virol 1997;71: 4707-16.
8. + hematopoietic stem cells of HIV-infected individuals. Hum Gene Ther 1997; 8:2229-38.
9. 9. Louache F, Henri A, Bettaieb A, et al. Role of immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 1992; 80:2991-9.
10. 10. Su L, Lee R, Bonyhadi M, et al. Hematopoietic stem cell based gene therapy for acquired immunodeficiency syndrome: efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro. Blood 1997; 89: 2283-90.
11. 11. Yu M, Leavitt MC, Yamada O, Young D, Ho AD, Wong-Staal F. Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1995; 92:699-703.
12. + peripheral blood stem cells from asymptomatic human immunodeficiency virus type-1 infected individuals mobilized with granulocyte colony stimulating factor. Blood 1997; 89: 4299-306.
13. 13. Nielsen SD, Dam-Larsen S, Nielsen C, Wantzin P, Mathiesen L, Hansen JES. Recombinant human granulocyte colony-stimulating factor increases circulating CD34 positive cells in patients with AIDS. Ann Hematol 1997; 74:215-20.
14. 14. Nielsen SD, Afzelius P, Dam-Larsen S, et al. Effect of granulocyte colony stimulating factor (G-CSF) in human immunodeficiency virus-infected patients: increase in numbers of naive CD4 cells and CD34 cells makes G-CSF a candidate for use in gene therapy or to support antiretroviral therapy. J Infect Dis 1998; 177:1733-6.
15. + progenitor cells by granulocyte colony stimulating factor in human immunodeficiency virus type 1-infected adults. Blood 1996;88:3329-35.
16. 16. Akkina RK, Rosenblatt JD, Campbell AG, Chen ISY, Zack JA. Modeling human lymphoid precursor cell gene therapy in SCID-hu mouse. Blood 1994; 84:1393-8.
17. 17. An DS, Koyanagi Y, Zhao JQ, et al. High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells. J Virol 1997; 71: 1397-404.
18. 18. Clark DR, Ampel NM, Hallett CA, Yedavalli VRK, DeLuca D. Peripheral blood from HIV-infected patients displays diminished T cell generation capacity. J Infect Dis 1997; 176:649-54.
19. + cells in vitro. Nat Med 1996; 2:46-51.
20. + cells. Blood 1994; 84: 104-10.
21. + compartment of adult bone marrow. Blood 1995; 85:2770-8.
22. 22. Jenkins M, Hanley MB, Moreno MB, Wieder E, McCune JM. Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo. Blood 1998; 91:2672-8.
23. 23. Koka PS, Fraser JK, Bryson Y, et al. Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo. J Virol 1998; 72:5121-7.
24. + bone marrow cells. J Exp Med 1993; 177:1531-9.
25. + single-positive T cells in murine fetal thymus organ culture. Proc Natl Acad Sci USA 1993; 90: 10778-82.
26. 26. Nielsen SD, Ersbøll AK, Mathiesen L, Nielsen JO, Hansen JES. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients. J Infect Dis 1998; 178: 1299-305.
27. + cells from bone marrow to peripheral blood is selective in steady-state hematopoiesis and during G-CSF administration. J Hematother 1997; 6:563-73.
28. 28. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992; 89:2804-8.
29. +, CD38 hematopoietic stem cells. Blood 1994; 83:1515-26.
30. + bone marrow cells. Blood 1994; 84: 1473-81.
31. +CD38- progenitor cells. Blood 1991;77: 1218-27.
32. 32. Gaulton GN, Scobie JV, Rosenzweig M. HIV-1 and the thymus. AIDS 1997; 11:403-14.
33. 33. Louache F, Debili N, Marandin A, Coulombel L, Vainchenker W. Expression of CD4 by hematopoietic progenitors. Blood 1994; 84:3344-55.
34. + hematopoietic progenitors express low levels of CD4, the high affinity receptor for human immunodeficiency virus type 1. Blood 1994; 84:1896-905.
35. 35. Lund O, Lund OS, Gram G, et al. Gene therapy of T helper cells in HIV infection: mathematical model of the criteria for clinical effect. Bull Math Biol 1997; 59:725-45.
36. 36. Hutchings M, Moriwaki K, Dilloo D, et al. Increased transduction efficiency of primary hematopoietic cells by physical colocalization of retrovirus and target cells. J Hematother 1998; 7:217-24.
37. + progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br J Haematol 1993; 85:20-4.
38. 38. Marandin A, Katz A, Oksenhendler E, et al. Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood 1996; 88:4568-78.
39. 39. Re MC, Zauli G, Furlini G, et al. The impaired number of circulating granulocyte/macrophage progenitors (CFC-GM) in human immuno-deficiency virus-type 1 infected subjects correlates with an active HIV-1 replication. Arch Virol 1993; 129:53-64.
40. 40. Sloand EM, Young NS, Sato T, et al. Secondary colony formation after long-term bone marrow culture using peripheral blood and bone marrow of HIV-infected patients. AIDS 1997; 11:1547-53.
41. + bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol 1992; 149:689-97.
42. 42. Davis BR, Schwartz DH, Marx JC, et al. Absent or rare human immuno-deficiency virus infection of bone marrow stem/progenitor cells in vivo. J Virol 1991;65:1985-90.
43. + progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 1995; 86:1749-56.
44. 44. McCune JM, Loftus R, Schmidt DK, et al. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest 1998; 101:2301-8.
45. 45. Withers-Ward ES, Amado RG, Koka PS, et al. Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy. Nat Med 1997; 3:1102-9.
46. + hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients. Haematologica 1996; 81:216-23.
47. 47. Dührsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D. Effects of recombinant human granulocyte colony stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72:2074-81.
48. 48. Fujisaki T, Otsuka T, Harada M, Ohno Y, Niho Y. Granulocyte colony stimulating factor mobilizes primitive hematopoietic stem cells in normal individuals. Bone Marrow Transplant 1995; 16:57-62.
49. + peripheral blood progenitor cells. Ann Hematol 1995; 71:105-10.
50. 50. van der Loo JC, Ploemacher RE. Marrow-and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood 1995; 85:2598-606.
51. 51. Schmitt C, Ktorza S, Sarun S, Blanc C, De Jong R, Debre P. CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential. Blood 1993; 82:3675-85.